Health
2 analysis pieces
HealthThe Obesity Drug Revolution
GLP-1 receptor agonists like semaglutide and tirzepatide have transformed obesity treatment. Clinical trials show 15-25 percent body weight reduction, approaching the effectiveness of bariatric surgery without the surgical risk. Demand has exceeded supply. The drugs reduce cardiovascular risk factors and may have benefits for kidney disease and addiction. Long-term safety data is still being collected. The economic implications are enormous: reduced healthcare costs could offset the high drug prices within a decade.
HealthLong COVID Research Accelerates
An estimated 65 million people worldwide experience long COVID symptoms. Research has identified several potential mechanisms: viral persistence, immune system dysregulation, blood vessel damage, and autoimmune responses. Clinical trials are testing antivirals, anti-inflammatory drugs, and rehabilitation protocols. The condition has reshaped disability policy, with many countries recognizing long COVID as a qualifying condition for workplace accommodations and social support.